Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma.
about
Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinomaCyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma.Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma.Systematic review: Cyclo-oxygenase-2 in human oesophageal adenocarcinogenesis.Molecular biological challenges in he treatment of esophageal adenocarcinoma.Cyclooxygenase inhibitors: scope of their use and development in cancer chemotherapy.Integration of targeted agents in the neo-adjuvant treatment of gastro-esophageal cancers.CD24 Expression Is Increased in 5-Fluorouracil-Treated Esophageal Adenocarcinoma Cells.Celecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancer.
P2860
Q28085367-C6E5E353-9E45-4476-829C-0489BE35A5ABQ35884306-F0161194-4325-4CBA-B9F3-E97B25F2279CQ36510119-1A730D2D-0AF6-4FA0-B4CF-1D1A6FBFA5AAQ36632320-553DC115-19AB-4A5B-939E-1A5AB57E5110Q37345996-B802BE6E-17A4-421E-AF8C-BB66D16A446AQ37646513-3964198E-D295-4C04-AD82-16EED12FD8BCQ39933959-CE1C2984-48A5-4E26-8B75-BFEC1E291644Q42240172-49DC5908-7D81-431D-B579-906332E70BE2Q42395422-44165F68-75B7-4955-96F9-131566E1D106
P2860
Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Neoadjuvant selective COX-2 in ...... ith esophageal adenocarcinoma.
@en
Neoadjuvant selective COX-2 in ...... ith esophageal adenocarcinoma.
@nl
type
label
Neoadjuvant selective COX-2 in ...... ith esophageal adenocarcinoma.
@en
Neoadjuvant selective COX-2 in ...... ith esophageal adenocarcinoma.
@nl
prefLabel
Neoadjuvant selective COX-2 in ...... ith esophageal adenocarcinoma.
@en
Neoadjuvant selective COX-2 in ...... ith esophageal adenocarcinoma.
@nl
P2093
P2860
P1433
P1476
Neoadjuvant selective COX-2 in ...... ith esophageal adenocarcinoma.
@en
P2093
Christianne J Buskens
Dirk J Richel
Fiebo J W ten Kate
G Johan A Offerhaus
J Jan B van Lanschot
Jurriaan B Tuynman
Kristel Kemper
P2860
P304
840-9, discussion 849-50
P356
10.1097/01.SLA.0000189546.77520.EF
P407
P577
2005-12-01T00:00:00Z